UB Paderborn / Katalog / Suche / in CDI

1 – 8 von 8

Sortiert nach

Risk of virological failure in HIV-1-infected patients experiencing low-level viraemia under active antiretroviral therapy (ANRS C03 cohort study)

Antiviral therapy, 2015, Vol.20 (6), p.655-660

2015

Link zum Volltext

Verfügbarkeit prüfen

Time to Treatment Initiation and HIV Viral Suppression in People Diagnosed With HIV-1 During COVID-19 Pandemic in Ex-Aquitaine, France (ANRS CO3 AQUIVIH-NA Cohort-QuAliCOV Study)

Journal of acquired immune deficiency syndromes (1999), 2024-01, Vol.95 (1), p.1

2024

Link zum Volltext

Verfügbarkeit prüfen

Long-term follow-up of HIV-1 multi-drug-resistant treatment-experienced participants treated with etravirine, raltegravir and boosted darunavir: towards drug-reduced regimen? ANRS CO3 Aquitaine Cohort 2007–2018

International journal of antimicrobial agents, 2023-01, Vol.61 (1), p.106696-106696, Article 106696

2023

Link zum Volltext

Verfügbarkeit prüfen

Statin use and risk of severe bacterial infection in a population living with HIV: prospective cohort study of the ANRS CO3 Aquitaine Cohort 2000–2018

Clinical microbiology and infection, 2021-09, Vol.27 (9), p.1301-1307

2021

Link zum Volltext

Verfügbarkeit prüfen

Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010–19: an analysis of data from a consortium of prospective cohort studies

The lancet HIV, 2024-02, Vol.11 (2), p.e106-e116

2024

Link zum Volltext

Verfügbarkeit prüfen

Cohort Profile: International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC)

International journal of epidemiology, 2024-02, Vol.53 (1)

2024

Link zum Volltext

Verfügbarkeit prüfen

Week 96 efficacy of lopinavir/ritonavir monotherapy in virologically suppressed patients with HIV: a randomized non-inferiority trial (ANRS 140 DREAM)

Journal of antimicrobial chemotherapy, 2018-06, Vol.73 (6), p.1672-1676

2018

Link zum Volltext

Verfügbarkeit prüfen

Accelerating clinical development of HIV vaccine strategies: methodological challenges and considerations in constructing an optimised multi-arm phase I/II trial design

Trials, 2014-02, Vol.15 (1), p.68-68, Article 68

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 8 von 8

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(8)
Mit Volltextzugriff
(7)

Publikationsform

Artikel
(8)

Sprache

Englisch
(8)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Risk of virological failure in HIV-1-infected patients experiencing low-level viraemia under active antiretroviral therapy (ANRS C03 cohort study)

Time to Treatment Initiation and HIV Viral Suppression in People Diagnosed With HIV-1 During COVID-19 Pandemic in Ex-Aquitaine, France (ANRS CO3 AQUIVIH-NA Cohort-QuAliCOV Study)

Long-term follow-up of HIV-1 multi-drug-resistant treatment-experienced participants treated with etravirine, raltegravir and boosted darunavir: towards drug-reduced regimen? ANRS CO3 Aquitaine Cohort 2007–2018

Statin use and risk of severe bacterial infection in a population living with HIV: prospective cohort study of the ANRS CO3 Aquitaine Cohort 2000–2018

Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010–19: an analysis of data from a consortium of prospective cohort studies

Cohort Profile: International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC)

Week 96 efficacy of lopinavir/ritonavir monotherapy in virologically suppressed patients with HIV: a randomized non-inferiority trial (ANRS 140 DREAM)

Accelerating clinical development of HIV vaccine strategies: methodological challenges and considerations in constructing an optimised multi-arm phase I/II trial design

Suchergebnisse filtern